喉癌

Pelucchi C, Gallus S, Garavello W, et al. Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver. Alcohol Res Health. 2006;29:193-198.

• 摘要

Troell RJ, Terris DJ. Detection of metastases from head and neck cancers. Laryngoscope. 1995 Mar;105(3 Pt 1):247-50.

• 摘要

Lefebvre JL, Ang KK; Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: key issues and recommendations: a consensus panel summary. Head Neck. 2009 Apr;31(4):429-41.

• 摘要

Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006 Feb 9;354(6):567-78.

• 全文
• 摘要

Brouwer J, Hooft L, Hoekstra OS, et al. Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck. 2008 Jul;30(7):889-97.

• 摘要

1.  Amin MB, Edge S, Green F, et al. AJCC cancer staging manual. 8th ed. (2017). Cham, Switzerland: Springer International; 2017.

2.  Agarwal V, Branstetter BF 4th, Johnson JT. Indications for PET/CT in the head and neck. Otolaryngol Clin North Am. 2008;41:23-49.

• 摘要

3.  Adams GL, Maisel RH. Malignant tumors of the larynx and hypopharynx. In: Cummings otolaryngology: head and neck surgery. Cummings CW, Flint PW, Harker LA, et al, eds. 4th ed. Philadelphia, PA: Elsevier Mosby; 2005:2222-2283.

4.  American Cancer Society. Cancer facts and figures 2016. Atlanta, GA: American Cancer Society, Inc; 2016.

• 全文

5.  Villanueva-Reyes A, Strand E, Nazario CM, et al. Cancer of the larynx in Puerto Rico. P R Health Sci J. 2008;27:196-203.

• 摘要

6.  Coupland VH, Chapman P, Linklater KM, et al. Trends in the epidemiology of larynx and lung cancer in south-east England, 1985-2004. Br J Cancer. 2009;100:167-169.

• 摘要

7.  Sapkota A, Hsu CC, Zaridze D, et al. Dietary risk factors for squamous cell carcinoma of the upper aerodigestive tract in central and eastern Europe. Cancer Causes Control. 2008;19:1161-1170.

• 摘要

8.  Andersen ZJ, Lassen CF, Clemmensen IH. Social inequality and incidence of and survival from cancers of the mouth, pharynx and larynx in a population-based study in Denmark, 1994-2003. Eur J Cancer. 2008;44:1950-1961.

• 摘要

9.  American Cancer Society. Cancer facts & figures: 2008. 2008. http://www.cancer.org (last accessed 28 October 2016).

• 全文

10.  Agrawal N, Ha PK. Management of early-stage laryngeal cancer. Otolaryngol Clin North Am. 2008;41:757-769.

• 摘要

11.  Devlin JG, Langer CJ. Combined modality treatment of laryngeal squamous cell carcinoma. Expert Rev Anticancer Ther. 2007;7:331-350.

• 摘要

12.  Van Cauwenberge P, Dhooge I, Ingels K. Epidemiology and etiological factors of laryngeal cancer. Acta Otorhinolaryngol Belg. 1992;46:99-102.

• 摘要

13.  Altumbabic H, Salkic A, Ramas A, et al. Pattern of head and neck malignant tumours in a Tuzla ENT clinic - a five year experience. Bosnian J Basic Med Sci. 2008;8:377-380.

• 摘要

14.  Bien S, Kaminski B, Zylka S, et al. Evolution of the epidemiology and clinical characteristics of larynx and hypopharynx carcinoma in Poland from 1991 to 2001. Eur Arch Otorhinolaryngol. 2008;265(suppl 1):S39-S46.

• 摘要

15.  Egeli U, Ozkan L, Tunca B, et al. The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites. Head Neck. 2000;22:591-598.

• 摘要

16.  Bagnardi V, Blangiardo M, La Vecchia C, et al. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer. 2001;85:1700-1705.

• 全文
• 摘要

17.  Pelucchi C, Gallus S, Garavello W, et al. Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver. Alcohol Res Health. 2006;29:193-198.

• 摘要

18.  British Association of Endocrine and Thyroid Surgeons. Head, neck and thyroid cancers 2012 - vision paper. 2010.

19.  Hoffman HT, Iseli TA, Karnell LH, et al. Management of early glottic cancer. In: Cummings CW, Flint PW, Haughey BH, et al, eds. Cummings otolaryngology: head and neck surgery. 4th ed. Philadelphia, PA: Elsevier Mosby; 2005:2285-2325.

20.  Altieri A, Garavello W, Bosetti C, et al. Alcohol consumption and risk of laryngeal cancer. Oral Oncol. 2005;41:956-965.

• 摘要

21.  El-Serag HB, Hepworth EJ, Lee P, et al. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol. 2001;96:2013-2018.

• 摘要

22.  Galli J, Cammarota G, Calo L, et al. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope. 2002;112:1861-1865.

• 摘要

23.  van der Laan BF, Baris G, Gregor RT, et al. Radiation-induced tumours of the head and neck. J Laryngol Otol. 1995;109:346-349.

• 摘要

24.  Yu KK, Zanation AM, Moss JR, et al. Familial head and neck cancer: molecular analysis of a new clinical entity. Laryngoscope. 2002;112:1587-1593.

• 摘要

25.  Ha PK, Califano JA 3rd. The molecular biology of laryngeal cancer. Otolaryngol Clin North Am. 2002;35:993-1012.

• 摘要

26.  Renan MJ. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog. 1993;7:139-146.

• 摘要

27.  Rees L, Birchall M, Bailey M, et al. A systematic review of case-control studies of human papillomavirus infection in laryngeal squamous cell carcinoma. Clin Otolaryngol Allied Sci. 2004;29:301-306.

• 摘要

28.  International Agency for Research on Cancer. Tobacco smoke and involuntary smoking: summary of data reported and evaluation. Lyon, France: IARC; 2002.

• 全文

29.  Geisler SA, Olshan AF. GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol. 2001 Jul 15;154(2):95-105.

• 全文
• 摘要

30.  Wight R, Paleri V, Arullendran P. Current theories for the development of nonsmoking and nondrinking laryngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2003 Apr;11(2):73-7.

• 摘要

31.  Frumkin H. Agent Orange and cancer: an overview for clinicians. CA Cancer J Clin. 2003 Jul-Aug;53(4):245-55.

• 全文
• 摘要

32.  Lindeberg H, Elbrond O. Malignant tumours in patients with a history of multiple laryngeal papillomas: the significance of irradiation. Clin Otolaryngol Allied Sci. 1991 Apr;16(2):149-51.

• 摘要

33.  Qadeer MA, Lopez R, Wood BG, et al. Does acid suppressive therapy reduce the risk of laryngeal cancer recurrence? Laryngoscope. 2005;115:1877-1881.

• 摘要

34.  Seoane JT. Impact of delay in diagnosis on survival to head and neck carcinomas: a systematic review with meta-analysis. Clin Otolaryngol. 2012 Apr;37(2):99-106.

• 摘要

35.  Troell RJ, Terris DJ. Detection of metastases from head and neck cancers. Laryngoscope. 1995 Mar;105(3 Pt 1):247-50.

• 摘要

36.  Cancer Care Ontario. PET imaging in head and neck cancer. February 2012 [internet publication].

• 全文

37.  Kraft M, Betz CS, Leunig A, et al. Value of fluorescence endoscopy for the early diagnosis of laryngeal cancer and its precursor lesions. Head & Neck. 2011 Jul;33(7):941-8.

• 摘要

38.  Tesic-Vidovic L. Laryngeal tuberculosis: a report of three cases. Internet J Otorhinolaryngol. 2006;4.

39.  Dipika A, Balakrishnan C, Nene A, et al. Upper airways involvement in Wegener's granulomatosis: a case report and review. J Indian Rheumatol Assoc. 2004;12:127-29.

• 全文

40.  National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. June 2015 [internet publication].

• 全文

41.  NCCN Clinical Practice Guidelines in Oncology. Head and neck cancers. Version 2.2016 [internet publication].

• 全文

42.  Thomas L, Drinnan M, Natesh B, et al. Open conservation partial laryngectomy for laryngeal cancer: a systematic review of English language literature. Cancer Treat Rev. 2012 May;38(3):203-11.

• 摘要

43.  Feng YW. Comparison of preoperative radiation and surgery with surgery alone for laryngeal carcinoma. Cancer Treat Rev. 2010;17:1949-52.

44.  Forastiere AA, Ismaila N, Lewin JS, et al. Use of larynx-preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2018 Apr 10;36(11):1143-69.

• 全文
• 摘要

45.  Bradley PJ, Mackenzie K, Wight R, et al. Consensus statement on management in the UK: transoral laser assisted microsurgical resection of early glottic cancer. Clin Otolaryngol. 2009 Aug;34(4):367-73.

• 摘要

46.  Higgins KM, Shah MD, Ogaick MJ, et al. Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy. J Otolaryngol Head Neck Surg. 2009 Dec;38(6):603-12.

• 摘要

47.  Warner L, Chudasama J, Kelly CG, et al. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev. 2014 Dec 12;(12):CD002027.

• 全文
• 摘要

48.  Spielmann PM, Majumdar S, Morton RP, et al. Quality of life and functional outcomes in the management of early glottic carcinoma: a systematic review of studies comparing radiotherapy and transoral laser microsurgery. Clin Otolaryngol. 2010 Oct;35(5):373-82.

• 摘要

49.  Tandon S, Munir N, Roland NJ, et al. A systematic review and number needed to treat analysis to guide the management of the neck in patients with squamous cell carcinoma of the head and neck. Auris Nasus Larynx. 2011 Dec;38(6):702-9.

• 摘要

50.  Chen AY, Halpern M. Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2007 Dec;133(12):1270-6.

• 全文
• 摘要

51.  Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991 Jun 13;324(24):1685-90.

• 摘要

52.  Bourhis JS, Martin LA, ly-Schveitzer NS, et al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncology. 2012 Feb;13(2):145-53.

• 摘要

53.  Ghadjar PS, Zimmermann FB. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94). Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):524-31.

• 摘要

54.  Ang KK, Zhang Q, Rosenthal DI, et al. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014 Sep 20;32(27):2940-50.

• 全文
• 摘要

55.  Nguyen-Tan PF, Zhang Q, Ang KK, et al. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. J Clin Oncol. 2014 Dec 1;32(34):3858-66.

• 全文
• 摘要

56.  Wee JT, Anderson BO, Corry J, et al. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009 Nov;10(11):1086-92.

• 摘要

57.  Lefebvre JL, Ang KK; Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: key issues and recommendations: a consensus panel summary. Head Neck. 2009 Apr;31(4):429-41.

• 摘要

58.  Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013 Mar 1;31(7):845-52.

• 全文
• 摘要

59.  Hristov B, Bajaj GK. Radiotherapeutic management of laryngeal carcinoma. Otolaryngol Clin North Am. 2008 Aug;41(4):715-40.

• 摘要

60.  Paleri V, Thomas L, Basavaiah N, et al. Oncologic outcomes of open conservation laryngectomy for radiorecurrent laryngeal carcinoma: a systematic review and meta-analysis of English-language literature. Cancer. 2011 Jun 15;117(12):2668-76.

• 摘要

61.  Ferlito A, Haigentz M Jr, Bradley PJ, et al. Causes of death of patients with laryngeal cancer. Eur Arch Otorhinolaryngol. 2014 Mar;271(3):425-34.

• 摘要

62.  Caudell JJ, Sawrie SM, Spencer SA, et al. Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment. Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):676-81.

• 摘要

63.  Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006 Feb 9;354(6):567-78.

• 全文
• 摘要

64.  Brouwer J, Hooft L, Hoekstra OS, et al. Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck. 2008 Jul;30(7):889-97.

• 摘要

65.  American College of Radiology. ACR Appropriateness Criteria: retreatment of recurrent head and neck cancer after prior definitive radiation. 2014 [internet publication].

• 全文

66.  Zhang X, Zhang H, Tighiouart M, et al. Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor. Int J Cancer. 2008 Sep 1;123(5):1005-14.

• 摘要

67.  Zhang X, Chen ZG, Khuri FR, et al. Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck. Head Neck. 2007 Apr;29(4):351-61.

• 摘要

68.  Posner MR, Hershock DM, Blajman CR, et al; TAX 324 Study Group. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007 Oct 25;357(17):1705-15.

• 全文
• 摘要

69.  Seiwert TY, Burtness B, Mehra R, et al. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Lancet Oncol. 2016 Jul;17(7):956-65.

• 摘要

70.  Harrington KJ, Ferris RL, Blumenschein G Jr, et al. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Lancet Oncol. 2017 Aug;18(8):1104-15.

• 摘要

71.  ClinicalTrials.gov. Chemotherapy with or without bevacizumab in treating patients with recurrent or metastatic head and neck cancer. January 2016 [internet publication].

• 全文

72.  William WN Jr, Kim ES, Herbst RS. Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck. Nat Clin Pract Oncol. 2009 Mar;6(3):132-3.

• 摘要

73.  Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008 Sep 11;359(11):1116-27.

• 全文
• 摘要

74.  Biel MA. Photodynamic therapy and the treatment of neoplastic diseases of the larynx. Laryngoscope. 1994 Apr;104(4):399-403.

• 摘要

75.  Biel MA. Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem Photobiol. 2007 Sep-Oct;83(5):1063-8.

• 摘要

76.  Hoffman HT, Porter KP, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngscope. 2006;116:1-13.

• 摘要

77.  Cosetti M, Yu GP, Schantz SP. Five-year survival rates and time trends of laryngeal cancer in the US population. Arch Otolaryngol Head Neck Surg. 2008;134:370-379.

• 全文
• 摘要

78.  Cancer Research UK. Statistics and outlook for cancer of the larynx. July 2015. http://www.cancerhelp.org.uk (last accessed 28 October 2016).

• 全文

79.  Meyer FF. Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1454-62.

• 摘要

80.  Jacobi I, van der Molen L, Huiskens H, et al. Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol. 2010 Oct;267(10):1495-505.

• 全文
• 摘要

81.  Seixas-Silva JA Jr, Richards T, Khuri FR, et al. Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up. Arch Otolaryngol Head Neck Surg. 2005;131:304-307.

• 全文
• 摘要

82.  Sporn MB, Dunlop NM, Newton DL, et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc. 1976;35:1332-1338.

• 摘要

83.  Khuri FR, Lee JJ, Lippman SM, et al. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 2006;98:441-450.

• 全文
• 摘要

84.  Zhang X, Chen ZG, Choe MS, et al. Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model. Clin Cancer Res. 2005;11:6261-6269.

• 全文
• 摘要